Cargando…
Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn’s colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease
Evidence link bacterial enterotoxins to apparent crypt-cell like cells (CCLCs), and Alpha Defensin 5 (DEFA5) expansion in the colonic mucosa of Crohn’s colitis disease (CC) patients. These areas of ectopic ileal metaplasia, positive for Paneth cell (PC) markers are consistent with diagnosis of CC. R...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942995/ https://www.ncbi.nlm.nih.gov/pubmed/33690604 http://dx.doi.org/10.1371/journal.pone.0246393 |
_version_ | 1783662409987129344 |
---|---|
author | Rana, Tanu Korolkova, Olga Y. Rachakonda, Girish Williams, Amanda D. Hawkins, Alexander T. James, Samuel D. Sakwe, Amos M. Hui, Nian Wang, Li Yu, Chang Goodwin, Jeffrey S. Izban, Michael G. Offodile, Regina S. Washington, Mary K. Ballard, Billy R. Smoot, Duane T. Shi, Xuan-Zheng Forbes, Digna S. Shanker, Anil M’Koma, Amosy E. |
author_facet | Rana, Tanu Korolkova, Olga Y. Rachakonda, Girish Williams, Amanda D. Hawkins, Alexander T. James, Samuel D. Sakwe, Amos M. Hui, Nian Wang, Li Yu, Chang Goodwin, Jeffrey S. Izban, Michael G. Offodile, Regina S. Washington, Mary K. Ballard, Billy R. Smoot, Duane T. Shi, Xuan-Zheng Forbes, Digna S. Shanker, Anil M’Koma, Amosy E. |
author_sort | Rana, Tanu |
collection | PubMed |
description | Evidence link bacterial enterotoxins to apparent crypt-cell like cells (CCLCs), and Alpha Defensin 5 (DEFA5) expansion in the colonic mucosa of Crohn’s colitis disease (CC) patients. These areas of ectopic ileal metaplasia, positive for Paneth cell (PC) markers are consistent with diagnosis of CC. Retrospectively, we: 1. Identified 21 patients with indeterminate colitis (IC) between 2000–2007 and were reevaluation their final clinical diagnosis in 2014 after a followed-up for mean 8.7±3.7 (range, 4–14) years. Their initial biopsies were analyzed by DEFA5 bioassay. 2. Differentiated ulcer-associated cell lineage (UACL) analysis by immunohistochemistry (IHC) of the CC patients, stained for Mucin 6 (MUC6) and DEFA5. 3. Treated human immortalized colonic epithelial cells (NCM460) and colonoids with pure DEFA5 on the secretion of signatures after 24hr. The control colonoids were not treated. 4. Treated colonoids with/without enterotoxins for 14 days and the spent medium were collected and determined by quantitative expression of DEFA5, CCLCs and other biologic signatures. The experiments were repeated twice. Three statistical methods were used: (i) Univariate analysis; (ii) LASSO; and (iii) Elastic net. DEFA5 bioassay discriminated CC and ulcerative colitis (UC) in a cohort of IC patients with accuracy. A fit logistic model with group CC and UC as the outcome and the DEFA5 as independent variable differentiator with a positive predictive value of 96 percent. IHC staining of CC for MUC6 and DEFA5 stained in different locations indicating that DEFA5 is not co-expressed in UACL and is therefore NOT the genesis of CC, rather a secretagogue for specific signature(s) that underlie the distinct crypt pathobiology of CC. Notably, we observed expansion of signatures after DEFA5 treatment on NCM460 and colonoids cells expressed at different times, intervals, and intensity. These factors are key stem cell niche regulators leading to DEFA5 secreting CCLCs differentiation ‘the colonic ectopy ileal metaplasia formation’ conspicuously of pathogenic importance in CC. |
format | Online Article Text |
id | pubmed-7942995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-79429952021-03-19 Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn’s colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease Rana, Tanu Korolkova, Olga Y. Rachakonda, Girish Williams, Amanda D. Hawkins, Alexander T. James, Samuel D. Sakwe, Amos M. Hui, Nian Wang, Li Yu, Chang Goodwin, Jeffrey S. Izban, Michael G. Offodile, Regina S. Washington, Mary K. Ballard, Billy R. Smoot, Duane T. Shi, Xuan-Zheng Forbes, Digna S. Shanker, Anil M’Koma, Amosy E. PLoS One Research Article Evidence link bacterial enterotoxins to apparent crypt-cell like cells (CCLCs), and Alpha Defensin 5 (DEFA5) expansion in the colonic mucosa of Crohn’s colitis disease (CC) patients. These areas of ectopic ileal metaplasia, positive for Paneth cell (PC) markers are consistent with diagnosis of CC. Retrospectively, we: 1. Identified 21 patients with indeterminate colitis (IC) between 2000–2007 and were reevaluation their final clinical diagnosis in 2014 after a followed-up for mean 8.7±3.7 (range, 4–14) years. Their initial biopsies were analyzed by DEFA5 bioassay. 2. Differentiated ulcer-associated cell lineage (UACL) analysis by immunohistochemistry (IHC) of the CC patients, stained for Mucin 6 (MUC6) and DEFA5. 3. Treated human immortalized colonic epithelial cells (NCM460) and colonoids with pure DEFA5 on the secretion of signatures after 24hr. The control colonoids were not treated. 4. Treated colonoids with/without enterotoxins for 14 days and the spent medium were collected and determined by quantitative expression of DEFA5, CCLCs and other biologic signatures. The experiments were repeated twice. Three statistical methods were used: (i) Univariate analysis; (ii) LASSO; and (iii) Elastic net. DEFA5 bioassay discriminated CC and ulcerative colitis (UC) in a cohort of IC patients with accuracy. A fit logistic model with group CC and UC as the outcome and the DEFA5 as independent variable differentiator with a positive predictive value of 96 percent. IHC staining of CC for MUC6 and DEFA5 stained in different locations indicating that DEFA5 is not co-expressed in UACL and is therefore NOT the genesis of CC, rather a secretagogue for specific signature(s) that underlie the distinct crypt pathobiology of CC. Notably, we observed expansion of signatures after DEFA5 treatment on NCM460 and colonoids cells expressed at different times, intervals, and intensity. These factors are key stem cell niche regulators leading to DEFA5 secreting CCLCs differentiation ‘the colonic ectopy ileal metaplasia formation’ conspicuously of pathogenic importance in CC. Public Library of Science 2021-03-09 /pmc/articles/PMC7942995/ /pubmed/33690604 http://dx.doi.org/10.1371/journal.pone.0246393 Text en © 2021 Rana et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Rana, Tanu Korolkova, Olga Y. Rachakonda, Girish Williams, Amanda D. Hawkins, Alexander T. James, Samuel D. Sakwe, Amos M. Hui, Nian Wang, Li Yu, Chang Goodwin, Jeffrey S. Izban, Michael G. Offodile, Regina S. Washington, Mary K. Ballard, Billy R. Smoot, Duane T. Shi, Xuan-Zheng Forbes, Digna S. Shanker, Anil M’Koma, Amosy E. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn’s colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease |
title | Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn’s colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease |
title_full | Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn’s colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease |
title_fullStr | Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn’s colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease |
title_full_unstemmed | Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn’s colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease |
title_short | Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn’s colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease |
title_sort | linking bacterial enterotoxins and alpha defensin 5 expansion in the crohn’s colitis: a new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942995/ https://www.ncbi.nlm.nih.gov/pubmed/33690604 http://dx.doi.org/10.1371/journal.pone.0246393 |
work_keys_str_mv | AT ranatanu linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT korolkovaolgay linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT rachakondagirish linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT williamsamandad linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT hawkinsalexandert linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT jamessamueld linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT sakweamosm linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT huinian linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT wangli linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT yuchang linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT goodwinjeffreys linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT izbanmichaelg linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT offodilereginas linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT washingtonmaryk linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT ballardbillyr linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT smootduanet linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT shixuanzheng linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT forbesdignas linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT shankeranil linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease AT mkomaamosye linkingbacterialenterotoxinsandalphadefensin5expansioninthecrohnscolitisanewinsightintotheetiopathogeneticanddifferentiationtriggersdrivingcolonicinflammatoryboweldisease |